Cushman & Wakefield has made Martin Robb head of its healthcare advisory team.
Robb joins the firm as a senior director from Christie & Co following 20 years advising on the healthcare sector.
Robb will be responsible for strengthening C&W’s coverage of a growing part of the property market and will head a team responsible the valuation of property and portfolios and investment advisory.
Among deals Robb has been involved in the past has been Formation Capital’s purchase of NHP and Omega Healthcare’s investment in Healthcare Homes.
Charles Smith, head of valuation and advisory UK at Cushman & Wakefield, said: “Martin’s impressive experience in the healthcare sector will be of enormous benefit to our business. We valued more than £18bn of alternative investments last year and are well placed to grow that considerably. Martin’s appointment will help us expand our service offering to build on our market-leading position.”
Martin is the latest recruit into Cushman & Wakefield’s valuation & Advisory business, following Carl Ridgley, who joined as a director in the hospitality team earlier this month.
